However, unlike dysferlin, myoferlin has recently also been found to be overexpressed in various human cancers and the altered vesicular trafficking and function of myoferlin has been linked to cancer cell proliferation, metastasis, and resistance to chemotherapy (Cooper and McNeil, 2015; Gupta et al, 2021; Zhang et al, 2018). This evidence concerns the gene MYOF and cancer.